Labeling and Purification of RNA Synthesized by In Vitro Transcription

  • Paul A. Clarke
Part of the Methods in Molecular Biology™ book series (MIMB, volume 118)

Abstract

The problems of isolating sufficient quantities of rare RNAs for detailed biochemical analysis can be circumvented by synthesis of the desired RNA in vitro (1, 2, 3). Early methods of in vitro transcription included the use of eukary-otic cell extracts or Escherichia coli RNA polymerase to transcribe DNA templates containing the appropriate promoter. Ideally, however, the optimal in vitro transcription system should require simple buffer components without need for preparation of extracts and should precisely initiate and terminate transcription at definable sites. In vitro bacteriophage transcription systems fulfill these criteria. Single-stranded RNA of the desired sequence can now be synthesized using commercially available SP6, T3, and T7 bacteriophage RNA polymerases that have a very high specificity for their respective promoters. Large quantities of RNA can be synthesized and used as substrates in assays involving translation, RNA processing, microinjection, or transfection. The RNA can be end-labeled for structural analysis or for examining RNA-protein interactions. Alternatively, the RNA can be internally labeled during transcription and used as a riboprobe for Southern/Northern blots, for RNase protection assays, or in the assays described previously.

References

  1. 1.
    Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., and Green, M. R. (1984) Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12, 7035–7056.PubMedCrossRefGoogle Scholar
  2. 2.
    Krieg, P. A. and Melton, D. A. (1987) In vitro synthesis with SP6 RNA polymerase. Methods Enzymol. 155, 397–415.PubMedCrossRefGoogle Scholar
  3. 3.
    Gurevich, V. V. (1996) Use of bacteriophage RNA polymerase in RNA synthesis. Methods Enzymol. 275, 382–397.PubMedCrossRefGoogle Scholar
  4. 4.
    Milligan, J. F., Groebe, D. R., Witherell, G. W., and Uhlenbeck, O. C. (1987) Oligoribo-nucleotide synthesis using T7 RNA polymerase and synthetic DNA template. Nucleic Acids Res. 15, 8783–8798.PubMedCrossRefGoogle Scholar
  5. 5.
    Clarke, P. A. and Mathews, M. B. (1995) Interactions between the double-stranded RNA binding motif and RNA: definition of the binding site for the interferon-induced protein kinase (PKR) on adenovirus VA RNA. RNA 1, 7–20.PubMedGoogle Scholar
  6. 6.
    Mellits, K. H., Pe’ery, T., Manche, L., Robertson, H. D., and Mathews, M. B. (1990) Removal of double-stranded contaminants from RNA transcripts: synthesis of adenovirus VA RNAI from a T7 vector. Nucleic Acids Res. 18, 5401–5406.PubMedCrossRefGoogle Scholar
  7. 7.
    Schenborn, E. T. and Mierindorf, R. C. (1985) A novel transcription property of SP6 and T7 RNA polymerases: dependence on template structure. Nucleic Acids Res. 13, 6223–6236.PubMedCrossRefGoogle Scholar
  8. 8.
    Krieg, P. A. (1991) Improved synthesis of full length RNA probe at reduced incubation temperatures. Nucleic Acids Res. 18, 6463CrossRefGoogle Scholar
  9. 9.
    Ling, M. L., Risman, S. S., Klement, J. P., McGraw, N., and McAllister, W. T. (1989) Abortive initiation by bacteriophage T3 and T7 polymerase under conditions of limiting substrate Nucleic Acids Res. 17, 1605–1618.PubMedCrossRefGoogle Scholar
  10. 10.
    Knapp, G. (1989) Enzymatic approaches to probing of RNA secondary and tertiary structure. Methods Enzymol. 180, 192–212.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1999

Authors and Affiliations

  • Paul A. Clarke
    • 1
  1. 1.Cancer Research Campaign (CRC) Centre for Cancer Therapeutics, Institute of Cancer ResearchRoyal Marsden HospitalSurreyUK

Personalised recommendations